Clik here to view.
Mobi来了：瑞思迈首款便携式制氧设备现在美国全面上市
圣迭戈 (美国商业资讯) — 呼吸医护医疗器械和院外医护软件的领先者瑞思迈(ResMed, NYSE: RMD, ASX: RMD)今天宣布，其精品级便携式氧浓缩仪Mobi现已在美国全面上市。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20190109005749/zh-CN/ ResMed Mobi...
View ArticleClik here to view.
血管内模拟技术专业公司Mentice委任首席临床官
瑞典哥德堡 (美国商业资讯)–全球领先的血管内手术治疗解决方案提供商Mentice今天宣布任命David J. Ballard博士为Mentice集团首席临床官兼执行副总裁。在此之前，Ballard博士于2018年10月出任Mentice董事会独立成员。...
View ArticleClik here to view.
LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic...
ALAMEDA, Calif. LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE) announced today that Tianjin Novogene Medical Laboratory, LifeMap, and Shanghai Shanyi today...
View ArticleClik here to view.
ファクトリーCROとボストン・バイオメディカル・アソシエイツが合併を発表
蘭ビルトホーフェン & 米マサチューセッツ州マールボロ （ビジネスワイヤ） — 医療機器と体外診断用医薬品（IVD）に傾注する世界一流の開発業務受託機関（CRO）のファクトリーCROグループと、米国に拠点を置く一流のフルサービス医療機器／バイオテクノロジーCROにしてコンサルティング企業のボストン・バイオメディカル・アソシエイツ（BBA）は、両組織の合併を発表しました。...
View ArticleClik here to view.
血管内シミュレーションの専門企業メンティスが最高臨床責任者を任命
スウェーデン・ヨーテボリ （ビジネスワイヤ） — 血管内パフォーマンスソリューションを提供する世界一流企業であるメンティスは本日、デビッド・J・バラード博士をメンティス・グループの最高臨床責任者（CCO）兼エグゼクティブバイスプレジデントに任命したことを発表しました。バラード博士は、すでに2018年10月にメンティス取締役会の独立役員に任命されています。...
View ArticleClik here to view.
Five Prime Therapeutics Announces Two Poster Presentations at the 2019...
SOUTH SAN FRANCISCO, Calif. Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein...
View ArticleClik here to view.
Terns Pharmaceuticals与上海拓臻生物科技有限公司宣布任命Erin Quirk医学博士为首席医学官
加州圣马特奥和中国上海 (美国商业资讯)–Terns Pharmaceuticals Inc. 是一家全球性生物制药公司（以下简称“拓瑧”），致力于治疗非酒精性脂肪性肝炎（NASH）和癌症的口服小分子创新药物的研发。该公司于今日宣布任命Erin Quirk, M.D.为首席医学官（Chief Medical...
View ArticleClik here to view.
Diaceutics Opens Asian Hub to Capitalize on Growing Market
SINGAPORE Diaceutics, the diagnostics data analytics and implementation services company, today announces that it is opening a new regional hub in Asia. With more than 10% of the company’s annual...
View ArticleClik here to view.
キアゲン、肺がんEGFR検査のコンパニオン診断薬としての承認を日本で取得
独ヒルデン & 東京 （ビジネスワイヤ） — キアゲン（NYSE：QGEN、フランクフルト・プライム・スタンダード：QIA）は本日、日本の医薬品医療機器総合機構（PMDA)が、EGFR遺伝子変異陽性の手術不能／再発性非小細胞肺がんに対するファイザーのVIZIMPRO®（ダコミチニブ）のコンパニオン診断薬としてのtherascreen® EGFR RGQ PCR...
View ArticleClik here to view.
New Leaders Join CDISC 2019 Board of Directors
AUSTIN, Texas CDISC today announced three new members have joined its Board of Directors. Dr. Pandu Kulkarni, Dr. Hiroshi Masumoto, and Dr. Zhengqing Li each began serving a three-year term at the...
View ArticleClik here to view.
Terns Pharmaceuticalsがエリン・クワーク医師を最高医学責任者に任命したと発表
米カリフォルニア州サンマテオ & 上海 （ビジネスワイヤ） — NASHおよびがんの治療を目的とした分子標的経口低分子薬の創薬と開発に傾注する世界的なバイオ医薬品企業のTerns Pharmaceuticals...
View ArticleClik here to view.
US FDA Approves ONTRUZANT® (trastuzumab-dttb), Samsung Bioepis’ First...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved ONTRUZANT® (trastuzumab-dttb), a biosimilar referencing HERCEPTIN® 1...
View ArticleClik here to view.
SanBio: Addition of a Cerebral Hemorrhage Program for SB623 Regenerative Cell...
TOKYO At a meeting held today, the Board of Directors of SanBio Co., Ltd. (hereinafter, the “Company”) resolved to add a program for treatment of chronic motor deficit from cerebral hemorrhage as a...
View ArticleClik here to view.
Clik here to view.
Metabolon任命Michael Rasche为国际业务总裁
北卡罗来纳州罗利和德国波茨坦 (美国商业资讯)–代谢组学领域的全球领导者Metabolon今天宣布，Michael Rasche加盟公司担任国际业务总裁。Michael将向Metabolon总裁兼首席执行官Rohan Hastie汇报，并担任公司执行团队成员。他将负责Metabolon所有国际业务活动，重点关注客户与团队拓展。...
View ArticleClik here to view.
Immunochina Raises $20.4 Million USD in Series C Financing
BEIJING Beijing-based Immunochina Pharmaceuticals today announced the closing of its $140 million RMB Series C financing (approximately $20.4 million in US Dollars). This financing will enable the...
View ArticleClik here to view.
PeptiDream Announces New Peptide Drug Conjugate (PDC) Discovery Deal with...
KAWASAKI, Japan PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a multi-program collaborative research...
View ArticleClik here to view.
Applied DNA Signs Memorandum of Understanding with Sun Chemical Supply...
STONY BROOK, N.Y. Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA,” “the Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced...
View ArticleClik here to view.
EpimAb Biotherapeutics Achieves Key Milestone with Lead Cancer Program EMB01
SHANGHAI EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, announced today completed recruitment of the first dose cohort in a...
View ArticleClik here to view.
Prenetics Group Expands Its Digital Health Solutions with Acquisition of...
LONDON Prenetics, a leading global genetics and digital health company, has today announced it has acquired Kelaa App, the core product of Soma Analytics and associated assets. Founded in Germany in...
View Article